NIAID Banner Logo Image

HIV Citation List: March 1 - March 14, 2013

PubMed citations

1. A Mutant Tat Protein Provides Strong Protection from HIV-1 Infection in Human CD4+ T Cells. Apolloni, A., M.H. Lin, H. Sivakumaran, D. Li, M.H. Kershaw, and D. Harrich. Human Gene Therapy, 2013. [Epub ahead of print]. PMID[23298160].
[PubMed]. HIV_0301-031413.


2. In Vitro Effects of the CCR5 Inhibitor Maraviroc on Human T Cell Function. Arberas, H., A.C. Guardo, M.E. Bargallo, M.J. Maleno, M. Calvo, J.L. Blanco, F. Garcia, J.M. Gatell, and M. Plana. The Journal of Antimicrobial Chemotherapy, 2013. 68(3): p. 577-586. PMID[23152485].
[PubMed]. HIV_0301-031413.


3. Solid-state Tautomeric Structure and Invariom Refinement of a Novel and Potent HIV Integrase Inhibitor. Bacsa, J., M. Okello, P. Singh, and V. Nair. Acta Crystallographica. Section C, Crystal Structure Communications, 2013. 69(Pt 3): p. 285-288. PMID[23459357].
[PubMed]. HIV_0301-031413.


4. Inhibition of HIV-1 Replication by HTLV-1/2 Tax Proteins in Vitro. Beilke, M., C.S. Barrios, L. Castillo, C.Z. Giam, and L. Wu. AIDS Research and Human Retroviruses, 2013. [Epub ahead of print]. PMID[23464580].
[PubMed]. HIV_0301-031413.


5. HIV-2 Susceptibility to Entry Inhibitors. Borrego, P. and N. Taveira. AIDS Reviews, 2013. 15(1): p. 49-61. PMID[23449229].
[PubMed]. HIV_0301-031413.


6. Short-peptide Fusion Inhibitors with High Potency against Wild-type and Enfuvirtide-resistant HIV-1. Chong, H., X. Yao, Z. Qiu, J. Sun, M. Zhang, S. Waltersperger, M. Wang, S.L. Liu, S. Cui, and Y. He. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 2013. 27(3): p. 1203-1213. PMID[23233535].
[PubMed]. HIV_0301-031413.


7. A Model of the Peptide Triazole Entry Inhibitor Binding to HIV-1 gp120 and Mechanism of Bridging Sheet Disruption. Emileh, A., F. Tuzer, H.J. Yeh, M. Umashankara, D.R. Moreira, J.M. Lalonde, C.A. Bewley, C.F. Abrams, and I.M. Chaiken. Biochemistry, 2013. [Epub ahead of print]. PMID[23470147].
[PubMed]. HIV_0301-031413.


8. Identification of Novel Inhibitors of Human Immunodeficiency Virus Type 1 Replication by in Silico Screening Targeting Cyclin T1/Tat Interaction. Hamasaki, T., M. Okamoto, and M. Baba. Antimicrobial Agents and Chemotherapy, 2013. 57(3): p. 1323-1331. PMID[23274668].
[PubMed]. HIV_0301-031413.


9. HIV-1 and HSV-1 Virus Activities of Some New Polycyclic Nucleoside Pyrene Candidates. Khalifa, N.M., M.A. Al-Omar, G. Amr Ael, and M.E. Haiba. International Journal of Biological Macromolecules, 2013. 54: p. 51-56. PMID[23178400].
[PubMed]. HIV_0301-031413.


10. 9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and Its Prodrugs: Optimized Preparation, Including Identification of By-products Formed, and Antiviral Evaluation in Vitro. Krecmerova, M., P. Jansa, M. Dracinsky, P. Sazelova, V. Kasicka, J. Neyts, J. Auwerx, E. Kiss, N. Goris, G. Stepan, and Z. Janeba. Bioorganic & Medicinal Chemistry, 2013. 21(5): p. 1199-1208. PMID[23375089].
[PubMed]. HIV_0301-031413.


11. 3-Hydroxyphthalic anhydride-Modified Human Serum Albumin as a Microbicide Candidate Inhibits HIV Infection by Blocking Viral Entry. Li, L., J. Qiu, L. Lu, S. An, P. Qiao, S. Jiang, and S. Liu. The Journal of Antimicrobial Chemotherapy, 2013. 68(3): p. 573-576. PMID[23221626].
[PubMed]. HIV_0301-031413.


12. Synthesis and anti-HIV Activity of 2-Naphthyl Substituted DAPY Analogues as Non-Nucleoside Reverse Transcriptase Inhibitors. Liang, Y.H., Q.Q. He, Z.S. Zeng, Z.Q. Liu, X.Q. Feng, F.E. Chen, J. Balzarini, C. Pannecouque, and E.D. Clercq. Bioorganic & Medicinal Chemistry, 2010. 18(13): p. 4601-4605. PMID[20570527].
[PubMed]. HIV_0301-031413.


13. Synthesis and anti-HIV Evaluation of Novel 1,3-Disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs). Lin, Y., X. Liu, R. Yan, J. Li, C. Pannecouque, M. Witvrouw, and E. De Clercq. Bioorganic & Medicinal Chemistry, 2008. 16(1): p. 157-163. PMID[17964796].
[PubMed]. HIV_0301-031413.


14. The Potent Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitor HR212 Blocks Formation of the Envelope Glycoprotein gp41 Six-helix Bundle. Ouyang, W., T. An, D. Guo, S. Wu, and P. Tien. AIDS Research and Human Retroviruses, 2013. 29(3): p. 613-620. PMID[23308369].
[PubMed]. HIV_0301-031413.


15. Synthesis and Biological Evaluation of Phosphonate Analogues of Nevirapine. Parrish, J., L. Tong, M. Wang, X. Chen, E.B. Lansdon, C. Cannizzaro, X. Zheng, M.C. Desai, and L. Xu. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1493-1497. PMID[23375792].
[PubMed]. HIV_0301-031413.


16. Bifunctional Inhibition of HIV-1 Reverse Transcriptase: A First Step in Designing a Bifunctional Triphosphate. Piao, D., A. Basavapathruni, P. Iyidogan, G. Dai, W. Hinz, A.S. Ray, E. Murakami, J.Y. Feng, F. You, G.E. Dutschman, D.J. Austin, K.A. Parker, and K.S. Anderson. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1511-1518. PMID[23380374].
[PubMed]. HIV_0301-031413.


17. Biological Interaction between Sasa senanensis Rehder Leaf Extract and Toothpaste Ingredients. Sakagami, H., S. Amano, T. Yasui, K. Satoh, S. Shioda, T. Kanamoto, S. Terakubo, H. Nakashima, K. Watanabe, T. Sugiura, M. Kitajima, H. Oizumi, and T. Oizumi. In Vivo, 2013. 27(2): p. 275-284. PMID[23422490].
[PubMed]. HIV_0301-031413.


18. Fragment-based Discovery of 8-Hydroxyquinoline Inhibitors of the HIV-1 Integrase-LEDGF/p75 Interaction. Serrao, E., B. Debnath, H. Otake, Y. Kuang, F. Christ, Z. Debyser, and N. Neamati. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23445471].
[PubMed]. HIV_0301-031413.


19. Phenotypic Susceptibility to Antiretrovirals among Clades C, F, and B/F Recombinant Antiretroviral-naive HIV Type 1 Strains. Sucupira, M.C., P. Munerato, J. Silveira, A.F. Santos, L.M. Janini, M.A. Soares, and R.S. Diaz. AIDS Research and Human Retroviruses, 2013. [Epub ahead of print]. PMID[23398474].
[PubMed]. HIV_0301-031413.


20. Design, Synthesis, and Biological Evaluation of Highly Potent Small Molecule-peptide Conjugates as New HIV-1 Fusion Inhibitors. Wang, C., W. Shi, L. Cai, L. Lu, Q. Wang, T. Zhang, J. Li, Z. Zhang, K. Wang, L. Xu, X. Jiang, S. Jiang, and K. Liu. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23458727].
[PubMed]. HIV_0301-031413.


21. Hydrogen-bond-directed Enantioselective Decarboxylative Mannich Reaction of beta-Ketoacids with Ketimines: Application to the Synthesis of anti-HIV Drug DPC 083. Yuan, H.N., S. Wang, J. Nie, W. Meng, Q. Yao, and J.A. Ma. Angewandte Chemie, 2013. [Epub ahead of print]. PMID[23460261].
[PubMed]. HIV_0301-031413.

ISI Web of Knowledge Citations

22. N-terminal Slit2 Inhibits HIV-1 Replication by Regulating the Actin Cytoskeleton. Anand, A.R., H.L. Zhao, T. Nagaraja, L.A. Robinson, and R.K. Ganju. Retrovirology, 2013. 10. ISI[000314718900002].
[WOS]. HIV_0301-031413.


23. Tautomeric Origin of Dual Effects of N1-Nicotinoyl-3-(4 '-hydroxy-3'-methyl phenyl)-5- (sub)phenyl -2-pyrazolines on Bacterial and Viral Strains: POM Analyses as New Efficient Bioinformatics' Platform to Predict and Optimize Bioactivity of Drugs. Ben Hadda, T., M.A. Ali, V. Masand, S. Gharby, T. Fergoug, and I. Warad. Medicinal Chemistry Research, 2013. 22(3): p. 1438-1449. ISI[000314283500041].
[WOS]. HIV_0301-031413.


24. Computational POM and 3D-QSAR Evaluation of Experimental in Vitro HIV-1-integrase Inhibition of Amide-containing Diketoacids. Ben Hadda, T., J. Fathi, I. Chafchaouni, V. Masand, Z. Charrouf, Z.H. Chohan, R. Jawarkar, T. Fergoug, and I. Warad. Medicinal Chemistry Research, 2013. 22(3): p. 1456-1464. ISI[000314283500043].
[WOS]. HIV_0301-031413.


25. BET Bromodomain-targeting Compounds Reactivate HIV from Latency via a Tat-independent Mechanism. Boehm, D., V. Calvanese, R.D. Dar, S.F. Xing, S. Schroeder, L. Martins, K. Aull, P.C. Li, V. Planelles, J.E. Bradner, M.M. Zhou, R.F. Siliciano, L. Weinberger, E. Verdin, and M. Ott. Cell Cycle, 2013. 12(3): p. 452-462. ISI[000314607100016].
[WOS]. HIV_0301-031413.


26. Optimization of Benzyloxazoles as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase to Enhance Y181C Potency. Bollini, M., R. Gallardo-Macias, K.A. Spasov, J. Tirado-Rives, K.S. Anderson, and W.L. Jorgensen. Bioorganic & Medicinal Chemistry Letters, 2013. 23(4): p. 1110-1113. ISI[000314625400038].
[WOS]. HIV_0301-031413.


27. Analysis by Substituted Cysteine Scanning Mutagenesis of the Fourth Transmembrane Domain of the CXCR4 Receptor in Its Inactive and Active State. Boulais, P.E., E. Escher, and R. Leduc. Biochemical Pharmacology, 2013. 85(4): p. 541-550. ISI[000314666700010].
[WOS]. HIV_0301-031413.


28. Heterocycles from Morita-Baylis-Hillman Adducts: Synthesis of 5-Oxopyrazolidines, Arylidene-5-oxopyrazolidines, and Oxo-2,5-dihydro-pyrazols. Correia, J.T.M., M.T. Rodrigues, H. Santos, C.F. Tormena, and F. Coelho. Tetrahedron, 2013. 69(2): p. 826-832. ISI[000314371800055].
[WOS]. HIV_0301-031413.


29. Identification of a 3-Aminoimidazo [1,2-a]pyridine Inhibitor of HIV-1 Reverse Transcriptase. Elleder, D., T.J. Baiga, R.L. Russell, J.A. Naughton, S.H. Hughes, J.P. Noel, and J.A.T. Young. Virology Journal, 2012. 9. ISI[000314312600001].
[WOS]. HIV_0301-031413.


30. Effector Kinase Coupling Enables High-throughput Screens for Direct HIV-1 Nef Antagonists with Antiretroviral Activity. Emert-Sedlak, L.A., P. Narute, S.T. Shu, J.A. Poe, H.B. Shi, N. Yanamala, J.J. Alvarado, J.S. Lazo, J.I. Yeh, P.A. Johnston, and T.E. Smithgall. Chemistry & Biology, 2013. 20(1): p. 82-91. ISI[000314436500011].
[WOS]. HIV_0301-031413.


31. Synthesis of the Reverse Transcriptase Inhibitor L-737,126 and the CB2 Cannabinoid Receptor Agonist Pravadoline by a Copper-catalyzed Intramolecular Cross-coupling. Gao, D.T. and T.G. Back. Synlett, 2013(3): p. 389-393. ISI[000314699200026].
[WOS]. HIV_0301-031413.


32. Docking and CoMFA Study on Novel Human CCR5 Receptor Antagonists. Ghasemi, J.B. and M. Nouri. Medicinal Chemistry Research, 2013. 22(3): p. 1356-1364. ISI[000314283500033].
[WOS]. HIV_0301-031413.


33. Computational Evaluation and Experimental in Vitro Antibacterial, Antifungal and Antiviral Activity of bis-Schiff Bases of Isatin and Its Derivatives. Jarrahpour, A., J. Sheikh, I. El Mounsi, H. Juneja, and T. Ben Hadda. Medicinal Chemistry Research, 2013. 22(3): p. 1203-1211. ISI[000314283500018].
[WOS]. HIV_0301-031413.


34. HIV Triggers Interleukin 21-Mediated Induction of Granzyme B-secreting B Cells with Regulatory and Antiviral Potential. Kaltenmeier, C., A. Gawanbacht, S. Lindner, T. Beyer, G. Haerter, B. Gruener, P. Kern, F. Kirchhoff, H. Schrezenmeier, and B. Jahrsdorfer. Blood, 2012. 120(21). ISI[000314049602031].
[WOS]. HIV_0301-031413.


35. Microwave-assisted Click Chemistry for Nucleoside Functionalization: Useful Derivatives for Analytical and Biological Applications. Krim, J., M. Taourirte, C. Grunewald, I. Krstic, and J.W. Engels. Synthesis-Stuttgart, 2013. 45(3): p. 396-405. ISI[000314632500019].
[WOS]. HIV_0301-031413.


36. The First Stereoselective Total Synthesis of Nicotlactone A. Krishna, P.R., S. Prabhakar, and C. Sravanthi. Tetrahedron Letters, 2013. 54(7): p. 669-671. ISI[000314743000015].
[WOS]. HIV_0301-031413.


37. Novel 2-Phenyl-1-pyridin-2yl-ethanone (PpY) Based Iron Chelators Increase Expression of IkB-alpha and Heme Oxygenase-1 and Inhibit HIV-1. Kumari, N., M. Xu, D. Kovlaskyy, S. Dhawan, and S. Nekhai. Blood, 2012. 120(21). ISI[000314049602021].
[WOS]. HIV_0301-031413.


38. Effect of Early Anti-retroviral Therapy on the Pathogenic Changes in Mucosal Tissues of SIV Infected Rhesus Macaques. Malzahn, J., C.L. Shen, L. Caruso, P. Ghosh, S.R. Sankapal, S. Barratt-Boyes, P. Gupta, and Y. Chen. Virology Journal, 2012. 9. ISI[000314779700001].
[WOS]. HIV_0301-031413.


39. A Highly Facile Approach to the Synthesis of Novel 2-(3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-N-phenylacetamides. Novikov, M.S., D.A. Babkov, M.P. Paramonova, A.O. Chizhov, A.L. Khandazhinskaya, and K.L. Seley-Radtke. Tetrahedron Letters, 2013. 54(6): p. 576-578. ISI[000314388300031].
[WOS]. HIV_0301-031413.


40. Anti-HIV, Antimycobacterial and Antimicrobial Studies of Newly Synthesized 1,2,4-Triazole Clubbed Benzothiazoles. Patel, N.B., I.H. Khan, C. Pannecouque, and E. De Clercq. Medicinal Chemistry Research, 2013. 22(3): p. 1320-1329. ISI[000314283500030].
[WOS]. HIV_0301-031413.


41. Divide-and-conquer-based Quantum Chemical Study for Interaction between HIV-1 Reverse Transcriptase and MK-4965 Inhibitor. Saparpakorn, P., M. Kobayashi, S. Hannongbua, and H. Nakai. International Journal of Quantum Chemistry, 2013. 113(4): p. 510-517. ISI[000313898900016].
[WOS]. HIV_0301-031413.


42. M48U1 CD4 Mimetic Has a Sustained Inhibitory Effect on Cell-associated HIV-1 by Attenuating Virion Infectivity through gp120 Shedding. Selhorst, P., K. Grupping, T. Tong, E.T. Crooks, L. Martin, G. Vanham, J.M. Binley, and K.K. Arien. Retrovirology, 2013. 10. ISI[000314831400002].
[WOS]. HIV_0301-031413.


43. Synthesis and anti-HIV Activity of Triazolo-fused 2 ',3 '-cyclic Nucleoside Analogs Prepared by an Intramolecular Huisgen 1,3-Dipolar Cycloaddition. Sun, J.B., R.H. Duan, H.M. Li, and J.C. Wu. Helvetica Chimica Acta, 2013. 96(1): p. 59-68. ISI[000313902600005].
[WOS]. HIV_0301-031413.


44. HIV Downregulates Interferon-stimulated Genes in Primary Macrophages. Wie, S.H., P.Y. Du, T.Q. Luong, S.E. Rought, N. Beliakova-Bethell, J. Lozach, J. Corbeil, R.S. Kornbluth, D.D. Richman, and C.H. Woelk. Journal of Interferon and Cytokine Research, 2013. 33(2): p. 90-95. ISI[000314875500007].
[WOS]. HIV_0301-031413.


45. Inhibition of P-glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages. Zha, W.B., G.J. Wang, W.R. Xu, X.Y. Liu, Y. Wang, B.S. Zha, J. Shi, Q.J. Zhao, P.M. Gerk, E. Studer, P.B. Hylemon, W.M. Pandak, and H.P. Zhou. Plos One, 2013. 8(1). ISI[000314021500062].
[WOS]. HIV_0301-031413.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022